In a nutshell This study aimed to investigate zoledronic acid in combination with chemotherapy as a treatment for HER2-negative breast cancer. This study concluded that the addition of zoledronic acid to chemotherapy has potential benefits for certain breast cancer patients. Some background HER2-negative breast cancer (BC) differs from...Read More
Breast cancer Posts on Medivizor
Update on guidelines for the use of adjuvant chemotherapy and targeted therapy in breast cancer patients.
In a nutshell This report summarized updates made to the guidelines for treatment of HER2-positive breast cancer with adjuvant chemotherapy and targeted therapy. Some background Adjuvant chemotherapy (treatment after surgery) is often used to prevent cancer recurrence. Chemotherapy involves agents that work to kill cancer cells in the body....Read More
In a nutshell This study aimed to compare fulvestrant (Faslodex) to other standard endocrine agents in patients with advanced hormone sensitive breast cancer. This study concluded that fulvestrant was as effective as the available standard endocrine agents. Some background Advanced hormone sensitive breast cancer (BC) is cancer that has...Read More
In a nutshell This study aimed to examine the effect of physical activity on cognitive function in breast cancer survivors. This study concluded that physical activity may have a positive impact on cognitive function in breast cancer survivors. Some background Breast cancer survivors can often suffer from cognitive impairment. Cognitive...Read More
Guidelines for the use of hormone therapy in hormone receptor-positive patients with metastatic breast cancer.
In a nutshell This report aimed to develop recommendations for endocrine therapy in women with hormone receptor-positive metastatic breast cancer. Some background Endocrine therapy, also known as hormone therapy (HT) is used to treat hormone receptor (HR) positive metastatic breast cancer (MBC). HR positive MBC depends on the hormones estrogen or...Read More
In a nutshell This study aimed to investigate the benefits of fulvestrant (Faslodex) treatment in advanced breast cancer patients. This study concluded that fulvestrant provides a benefit in patients with advanced breast cancer who have visceral metastasis. Some background Advanced breast cancer (ABC) has spread to the lymph nodes and...Read More
Is abemaciclib combined with fulvestrant effective in women with HR positive advanced breast cancer?
In a nutshell This study aimed to compare the effectiveness of the combination of fulvestrant (Faslodex) and abemaciclib to fulvestrant alone in patients with advanced breast cancer. This study concluded that the combination of fulvestrant and abemaciclib had improved outcomes for patients when compared to fulvestrant alone. Some background...Read More
In a nutshell This study aimed to investigate the use of Tai Chi Chih, a movement meditation, in treating insomnia in breast cancer (BC) survivors. This study concluded that both Tai Chi Chih and cognitive behavioral therapy for insomnia provide similar benefits for breast cancer survivors. Some background Breast cancer patients often...Read More
In a nutshell This study aimed to investigate the association between beta blocker use and outcomes in HER2 negative breast cancer (BC) patients. This study concluded that beta blocker use leads to improved progression free survival in BC patients. Some background Beta blockers are therapies used to treat various heart related conditions....Read More
In a nutshell This study aimed to investigate the frequency and severity of the adverse events associated with non-hormonal drugs (NHD) used to treat hot flashes in breast cancer survivor patients. This study concluded that the use of high-dose NHD led to increased rates of adverse events when compared to patients not using NHD. Some...Read More
In a nutshell This study aimed to investigate whether neoadjuvant systemic therapy (NST) influenced the eligibility of HER2 positive breast cancer patients to undergo breast conserving therapy (BCT). This study concluded the use of NST can result in patients who are non-eligible for BCT converting to patients that are eligible for BCT. Some...Read More
The impact of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on BC survival
In a nutshell This study investigated whether beta blockers (BB), angiotensin-converting enzyme inhibitors (ACEi), and angiotensin receptor blockers (ARB) have a beneficial effect on breast cancer-specific survival (BCSS; the time between diagnosis and death from BC). The use of BB was found to be associated with better BCSS survival. Some...Read More